Clinical Trial Update: Safety, Immunogenicity and Efficacy of Shigella Conjugate Vaccines in 1-4 Year Olds in Israel [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety, immunogenicity, and efficacy of Shigella conjugate vaccines in 1-4 year olds in Israel. The study is completed and results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Shigellosis

Drugs mentioned

• Shigella conjugate vaccine (Shigella conjugate vaccine)

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Shigellosis | Phase 3 | Status: COMPLETED | Results posted: 2012-06-19